Important Content Reminder
- Shanghai Youningwei Biotechnology Co., Ltd. (hereinafter referred to as "the Company") intends to use its own funds to repurchase a portion of its unrestricted A-share circulating stocks (hereinafter referred to as "this repurchase") through centralized bidding, for the purpose of implementing equity incentives or employee stock ownership plans. The total amount for this repurchase will not be less than RMB 15 million and not exceed RMB 30 million (inclusive); the repurchase price will not exceed RMB 45 per share (inclusive), and the specific number of shares repurchased will be based on the actual number at the end of the repurchase. The implementation period for this repurchase is within 12 months from the date the board of directors approves the repurchase plan.
- On May 26, 2026, the Company held the 13th meeting of the 4th board of directors, which approved the proposal on the repurchase of company shares. According to relevant laws and regulations and the Company’s Articles of Association, this repurchase plan can be approved by the board of directors with the attendance of more than two-thirds of the directors, without the need for submission to the shareholders' meeting.
- Regarding the reduction plans of relevant shareholders: As of the date of this report, the Company has not received any clear reduction plans from directors, senior management, controlling shareholders, actual controllers, and other shareholders holding more than 5% of shares during the repurchase period and the next three to six months. If any of the aforementioned parties implement share reduction plans in the future, the Company will fulfill its information disclosure obligations in a timely manner according to relevant regulations.
- The Company has opened a special securities account for repurchase at the Shenzhen branch of China Securities Depository and Clearing Co., Ltd., which will only be used for repurchasing company shares.
Risk Warning
- There is uncertainty risk that the repurchase plan may not be implemented or can only be partially implemented if the stock price exceeds the upper limit during the repurchase period.
- There are risks that significant events affecting the Company’s stock price, or major changes in the Company’s operations, financial status, or external conditions may lead to changes or termination of the repurchase plan, or the Company not meeting the legal requirements for share repurchase.
- The repurchased shares will be used for equity incentives or employee stock ownership plans, which may face risks of not being fully granted or being canceled if the plans are not approved by the board of directors or shareholders, or if the conditions for exercising rights are not met.
The Company will make repurchase decisions based on market conditions during the repurchase period and will fulfill its information disclosure obligations in a timely manner regarding the progress of the repurchase. Investors are advised to pay attention to investment risks.